Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03611049 · ClinicalTrials.gov registry record · Phase 2
Improving Functionality in Older People
A Phase 2 study, sponsored by Texas Tech University Health Sciences Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT03611049: Clinical Trial Phase 2 study, sponsored by Texas Tech University Health Sciences Center.
NCT03611049 is a Phase 2 study that was terminated before completion, run by Texas Tech University Health Sciences Center. The registered enrollment target is 14 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03611049, a Phase 2 study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
The study will examine if overall functionality of older adults with Vitamin D insufficiency can be improved by optimal Vitamin D replacement over a period of approximately one year. A variety of outcome metrics will be examined including mental and physical parameters
Primary Outcome
Muscle strength will be determined by hand grip
Interventions
- DIETARY_SUPPLEMENT High dose Vitamin D3
- DIETARY_SUPPLEMENT Low dose Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-07-19 |
| Phase | Phase 2 |
Why NCT03611049 stopped before completion
NCT03611049 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which High dose Vitamin D3 is the first listed.
NCT03611049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03611049 about?
NCT03611049 is a clinical study titled "Improving Functionality in Older People". The study will examine if overall functionality of older adults with Vitamin D insufficiency can be improved by optimal Vitamin D replacement over a period of approximately one year. A variety of outcome metrics will be examined including mental and physical parameters
What is the current status of trial NCT03611049?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2018-08-01. Estimated completion is 2019-07-19.
What interventions are being tested in trial NCT03611049?
The interventions under investigation include: High dose Vitamin D3 (DIETARY_SUPPLEMENT), Low dose Vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03611049?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03611049's enrollment target sits among peer trials
14 1941st of 2000 higher than 54 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy